Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

Journal of the National Cancer Institute

Volumn 99, Issue 11, 2007, Pages 838-846

  Taguchi, Fumiko ^a   Solomon, Benjamin ^a   Gregorc, Vanesa ^a   Roder, Heinrich ^a   Gray, Robert ^a   Kasahara, Kazuo ^a   Nishio, Makoto ^a   Brahmer, Julie ^a   Spreafico, Anna ^a   Ludovini, Vienna ^a   Massion, Pierre P ^a   Dziadziuszko, Rafal ^a   Schiller, Joan ^a   Grigorieva, Julia ^a   Tsypin, Maxim ^a   Hunsucker, Stephen W ^a   Caprioli, Richard ^a   Duncan, Mark W ^a   Hirsch, Fred R ^a   Bunn Jr , Paul A ^a   Carbone, David P ^a   more..

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; TUMOR MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD; CLASSIFICATION; CLINICAL TRIAL; DRUG ANTAGONISM; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; PROTEOMICS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN KINASE INHIBITORS; PROTEOMICS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34347393745     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk195     Document Type: Article

References (0)